<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000045150"><TermName>interleukin-3</TermName><TermPronunciation>(in-ter-LOO-kin...)</TermPronunciation><TermDefinition><DefinitionText>One of a group of related proteins made by leukocytes (white blood cells) and other cells in the body. Interleukin-3 is made mainly by a type of T lymphocyte. It increases the number of blood cells made by the bone marrow. Interleukin-3 made in the laboratory is used as a biological response modifier to boost the immune system in cancer therapy. Interleukin-3 is a type of cytokine.  Also called IL-3.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000705083" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;interleukin-3&quot;" language="en" id="_3"/><MediaLink ref="CDR0000705082" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;interleucina-3&quot;" language="es" id="_4"/><SpanishTermName>interleucina-3</SpanishTermName><SpanishTermDefinition><DefinitionText>Pertenece a un grupo de proteínas relacionadas que elaboran los leucocitos (glóbulos blancos) y otras células del cuerpo.   Principalmente un tipo de linfocito T elabora la interleucina-3. Esta aumenta el número de células sanguíneas que produce la médula ósea.     La interleucina-3 que se produce en el laboratorio se usa en el tratamiento de cáncer como modificador de la respuesta biológica para estimular el sistema inmunitario.        La interleucina-3 es un tipo de citocina. También se llama IL-3.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateLastModified>2010-07-19</DateLastModified></GlossaryTerm>
